Helixgate Biotech Review plans San Diego industry event on Oct. 22

Helixgate Biotech Review will stage its quarterly AI and biotech collaboration series and Industry Nights on Oct. 22, 2026, at Del Mar Social in San Diego. The day-to-night format is aimed at connecting life sciences companies, buyers, suppliers, investors and service providers through showcases, roundtables, dinner and networking.

Why it matters: - The San Diego event is built to connect buyers, sellers and partners across biotechnology, pharmaceuticals and life sciences in one setting. - Helixgate Biotech Review is using a quarterly format to create recurring business development and networking opportunities, not just a one-time meetup. - The program combines industry presentations with an evening social format, which could extend conversations and relationship-building beyond the daytime sessions.

What happened: - Helixgate Biotech Review announced the next quarterly Helixgate AI & Biotech Collaboration Series and Helixgate Industry Nights for Oct. 22, 2026. - The event will take place at Del Mar Social in San Diego, California. - The program runs from 12:00 p.m. to midnight and includes company showcases, roundtable discussions, an executive dinner, cocktails and the official after party. - The event is presented by Helixgate Biotech Review, which describes itself as a high-tech global digital intelligence publication covering biotechnology, pharmaceuticals and the broader life sciences industry.

The details: - The daytime Collaboration Series runs from 12:00 p.m. to 5:00 p.m. and includes company showcases, industry presentations, roundtable discussions, business development and networking. - The Executive Dinner, Industry Introductions & Networking runs from 5:00 p.m. to 6:30 p.m. - Cocktails and the evening transition are scheduled from 6:30 p.m. to 7:00 p.m. - Helixgate Industry Nights: The Official After Party runs from 7:00 p.m. to 12:00 a.m. and includes wine and cocktails, catering, DJs, live entertainment, networking, socializing and celebration. - Participation is expected to span drug discovery and therapeutics, clinical trials and development, regulatory affairs, synthetic biology, genomics, advanced therapeutics, deep tech, biomanufacturing, pharmaceutical manufacturing, CROs, CDMOs, clinical services, supply chains, laboratory equipment, commercialization, capital markets, global markets, universities, professional services and artificial intelligence. - The event is designed for organizations that discover, develop, manufacture, supply, finance, service, commercialize and purchase across life sciences. - Dedicated 6-foot showcase tables will give participating organizations space to present products, services, technologies, research and capabilities. - Outreach will focus on executives and professionals who buy, source, evaluate and procure those offerings. - Major sponsors will be visible across presentations, roundtables, networking, the executive dinner and the after party. - The quarterly structure is intended to give sponsors sustained visibility across future Helixgate gatherings.

Between the lines: - Helixgate is positioning the event as a commercial marketplace as much as an educational forum. - The format suggests a focus on matching adjacent parts of the life sciences ecosystem, including companies that can be both customers and suppliers to each other. - By tying the publication to live events, Helixgate is extending its brand beyond editorial coverage into recurring industry convening.

What's next: - Companies, organizations and professionals can participate through attendance, showcase tables, major sponsorships, strategic partnerships and broader collaboration. - Registration information is available through tickets and registration. - More information is available on the official website, the current quarterly issue and The Strathmore 2026 Report: The Great Therapeutic Divide. - Helixgate says future quarterly gatherings will let companies return with new products, services and developments.